Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

TERESA M DEANGELIS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1164463808
CMS profile
233693
Location
NEW YORK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$19,305.80

134 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

TERESA M DEANGELIS

NPI 1164463808 · CMS profile ID 233693

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

NEW YORK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1164463808?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
TERESA M DEANGELIS, NPI 1164463808, CMS profile ID 233693. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1164463808?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). TERESA M DEANGELIS, NPI 1164463808, CMS profile ID 233693. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1164463808?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
TERESA M DEANGELIS, NPI 1164463808, CMS profile ID 233693, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1164463808?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

134 matching records · $19,305.80 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 134 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–134 of 134.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
EMD Serono, Inc. $7.7404/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703012643 CMS
Teva Pharmaceuticals USA, Inc. $13.7104/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697832009 CMS
ACADIA Pharmaceuticals Inc $11.2504/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699998901 CMS
LivaNova USA, Inc. $12.1104/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703474343 CMS
Novartis Pharmaceuticals Corporation $12.4403/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659177561 CMS
EMD Serono, Inc. $15.6503/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702987073 CMS
Biogen, Inc. $17.1103/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666115 CMS
Lilly USA, LLC $13.1603/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658188147 CMS
Teva Pharmaceuticals USA, Inc. $15.6403/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697836461 CMS
Biogen, Inc. $3,150.0003/13/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666081 CMS
Biogen, Inc. $50.0003/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666083 CMS
ACADIA Pharmaceuticals Inc $11.7403/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699998899 CMS
Novartis Pharmaceuticals Corporation $20.3603/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658815215 CMS
Lundbeck LLC $15.1003/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684291663 CMS
Genentech USA, Inc. $15.3703/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681146587 CMS
Biogen, Inc. $13.7503/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666117 CMS
Novartis Pharmaceuticals Corporation $17.8103/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659177531 CMS
Novartis Pharmaceuticals Corporation $12.1702/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659177553 CMS
Teva Pharmaceuticals USA, Inc. $18.5502/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697820037 CMS
EMD Serono, Inc. $17.0702/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702981521 CMS
Lilly USA, LLC $11.1302/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658184971 CMS
Amgen Inc. $20.0802/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663110639 CMS
Biogen, Inc. $9.3202/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666109 CMS
Biogen, Inc. $1.2902/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666111 CMS
Biogen, Inc. $2.0102/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666113 CMS
GE HEALTHCARE $12.1402/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698469631 CMS
ACADIA Pharmaceuticals Inc $13.8301/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699998897 CMS
Lundbeck LLC $18.0601/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684291661 CMS
Biogen, Inc. $17.2601/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666101 CMS
Biogen, Inc. $1.0901/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666107 CMS
Biogen, Inc. $1.2101/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666105 CMS
Biogen, Inc. $0.9201/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666103 CMS
Novartis Pharmaceuticals Corporation $12.4401/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659177549 CMS
Biogen, Inc. $20.8301/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660666099 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $19,305.80 134
PY2020 $19,499.84 34
PY2021 $7,854.19 109
PY2022 $23,214.54 161
PY2023 $16,892.01 157
PY2024 $7,053.62 184
PY2025 $3,481.25 189

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $5,136.15 12
PY2024 Principal investigator $14,023.42 13
PY2023 Principal investigator $24,281.23 11
PY2022 Principal investigator $7,700.90 5
PY2021 Principal investigator $25,178.26 12
PY2020 Principal investigator $54,501.78 17
PY2019 Principal investigator $93,060.53 26

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $502.51 10/08/2025 Non-covered Recipient Entity
NEUROLOGY ASSOCIATES OF LONG ISLAND
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib No dispute reported 06/30/2026 1190303327
Principal investigator 1 Roche Products Limited $25.30 09/24/2025 Non-covered Recipient Entity
NEUROLOGICAL ASSOCIATES OF LONG ISLAND
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211627230
Principal investigator 1 Novartis Pharmaceuticals Corporation $2,200.00 07/15/2025 Non-covered Recipient Entity
NEUROLOGICAL ASSOCIATES OF LONG ISLAND, PC
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib No dispute reported 06/30/2026 1190313425
Principal investigator 1 Roche Products Limited $253.00 06/25/2025 Non-covered Recipient Entity
NEUROLOGICAL ASSOCIATES OF LONG ISLAND
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211627212
Principal investigator 1 Roche Products Limited $253.00 06/25/2025 Non-covered Recipient Entity
NEUROLOGICAL ASSOCIATES OF LONG ISLAND
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211627215
Principal investigator 1 Roche Products Limited $253.00 06/25/2025 Non-covered Recipient Entity
NEUROLOGICAL ASSOCIATES OF LONG ISLAND
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211627223
Principal investigator 1 Roche Products Limited $253.00 06/25/2025 Non-covered Recipient Entity
NEUROLOGICAL ASSOCIATES OF LONG ISLAND
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211627227
Principal investigator 1 Roche Products Limited $253.00 04/01/2025 Non-covered Recipient Entity
NEUROLOGICAL ASSOCIATES OF LONG ISLAND
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211627219
Principal investigator 1 Novartis Pharmaceuticals Corporation $384.34 01/31/2025 Non-covered Recipient Entity
NEUROLOGY ASSOCIATES OF LONG ISLAND
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib No dispute reported 06/30/2026 1190303329
Principal investigator 1 Roche Products Limited $253.00 01/09/2025 Non-covered Recipient Entity
NEUROLOGICAL ASSOCIATES OF LONG ISLAND
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211627201
Principal investigator 1 Roche Products Limited $253.00 01/09/2025 Non-covered Recipient Entity
NEUROLOGICAL ASSOCIATES OF LONG ISLAND
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211627205
Principal investigator 1 Roche Products Limited $253.00 01/09/2025 Non-covered Recipient Entity
NEUROLOGICAL ASSOCIATES OF LONG ISLAND
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211627208